[1]. Outcomes of COVID-19 in the Omicron-predominant wave: large-scale real-world data analysis with a comparison to influenza.
Pneumonia (Nathan Qld.) [巻]17 [号]1 [頁]3 （2025年） [査読] 有
[2]. Hypnotics and Mortality in Idiopathic Pulmonary Fibrosis: Hospital and National Data-Based Analysis.
Chest （2024年） [査読] 有
[3]. Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias.
Respiratory research [巻]25 [号]1 [頁]293 （2024年） [査読] 有
[4]. Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
RESPIRATORY RESEARCH [巻]25 [号]1 [頁]95 （2024年） [査読] 有
[URL] [DOI] [5]. Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study.
Emerging microbes & infections [巻]12 [号]1 [頁]2155250 （2023年） [査読] 有
[DOI]